Cargando…

Lack of correlation of stem cell markers in breast cancer stem cells

BACKGROUND: Various markers are used to identify the unique sub-population of breast cancer cells with stem cell properties. Whether these markers are expressed in all breast cancers, identify the same population of cells, or equate to therapeutic response is controversial. METHODS: We investigated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Y, Nenutil, R, Appleyard, M V, Murray, K, Boylan, M, Thompson, A M, Coates, P J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2014
Materias:	Molecular Diagnostics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3992489/ https://www.ncbi.nlm.nih.gov/pubmed/24577057 http://dx.doi.org/10.1038/bjc.2014.105

Ejemplares similares

Lack of correlation between markers of breast cancer initiating cells
por: Liu, Y, et al.
Publicado: (2010)

Sequential expression of putative stem cell markers in gastric carcinogenesis
por: Wang, T, et al.
Publicado: (2011)

Detection of oesophageal cancer biomarkers by plasma proteomic profiling of human cell line xenografts in response to chemotherapy
por: Kelly, P, et al.
Publicado: (2010)

Mesenchymal stem cells are enriched in head neck squamous cell carcinoma, correlates with tumour size and inhibit T-cell proliferation
por: Liotta, F, et al.
Publicado: (2015)

Gene set enrichment analysis provides insight into novel signalling pathways in breast cancer stem cells
por: Murohashi, M, et al.
Publicado: (2010)

Expansion of CD133(+) colon cancer cultures retaining stem cell properties to enable cancer stem cell target discovery
por: Fang, D D, et al.
Publicado: (2010)

Dynamic equilibrium between cancer stem cells and non-stem cancer cells in human SW620 and MCF-7 cancer cell populations
por: Yang, G, et al.
Publicado: (2012)

Isolation of tumour stem-like cells from benign tumours
por: Xu, Q, et al.
Publicado: (2009)

Integrin α3 is overexpressed in glioma stem-like cells and promotes invasion
por: Nakada, M, et al.
Publicado: (2013)

Circulating tumour cell-derived plastin3 is a novel marker for predicting long-term prognosis in patients with breast cancer
por: Ueo, H, et al.
Publicado: (2015)

Side population cells have the characteristics of cancer stem-like cells/cancer-initiating cells in bone sarcomas
por: Murase, M, et al.
Publicado: (2009)

Lack of EGF receptor contributes to drug sensitivity of human germline cells
por: Park, S-J, et al.
Publicado: (2005)

Prognostic impact of the expression of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM, and ALDH1 in colorectal cancer
por: Lugli, A, et al.
Publicado: (2010)

The requirement for freshly isolated human colorectal cancer (CRC) cells in isolating CRC stem cells
por: Fan, F, et al.
Publicado: (2015)

Chemoresistant colorectal cancer cells and cancer stem cells mediate growth and survival of bystander cells
por: Bose, D, et al.
Publicado: (2011)

Primary breast cancer stem-like cells metastasise to bone, switch phenotype and acquire a bone tropism signature
por: D′Amico, L, et al.
Publicado: (2013)

Disulfiram targets cancer stem-like cells and reverses resistance and cross-resistance in acquired paclitaxel-resistant triple-negative breast cancer cells
por: Liu, P, et al.
Publicado: (2013)

SOX2 regulates self-renewal and tumorigenicity of stem-like cells of head and neck squamous cell carcinoma
por: Lee, S H, et al.
Publicado: (2014)

Biglycan is a specific marker and an autocrine angiogenic factor of tumour endothelial cells
por: Yamamoto, K, et al.
Publicado: (2012)

IKKα is required in the intestinal epithelial cells for tumour stemness
por: Colomer, Carlota, et al.
Publicado: (2018)

Id-1 and Id-2 are markers for metastasis and prognosis in oesophageal squamous cell carcinoma
por: Yuen, H-F, et al.
Publicado: (2007)

Overexpression of matrix metalloproteinases and their inhibitors in mononuclear inflammatory cells in breast cancer correlates with metastasis-relapse
por: González, L O, et al.
Publicado: (2007)

Ovarian cancer stem-like side-population cells are tumourigenic and chemoresistant
por: Hu, L, et al.
Publicado: (2010)

Breast cancer expression of YKL-40 correlates with tumour grade, poor differentiation, and other cancer markers
por: Shao, R, et al.
Publicado: (2011)

MicroRNA expression profiling identifies miR-328 regulates cancer stem cell-like SP cells in colorectal cancer
por: Xu, X T, et al.
Publicado: (2012)

Molecular characterisation of side population cells with cancer stem cell-like characteristics in small-cell lung cancer
por: Salcido, C D, et al.
Publicado: (2010)

miR-30e* is an independent subtype-specific prognostic marker in breast cancer
por: D'Aiuto, F, et al.
Publicado: (2015)

TEAD1 and c-Cbl are novel prostate basal cell markers that correlate with poor clinical outcome in prostate cancer
por: Knight, J F, et al.
Publicado: (2008)

Circulating cell-free miRNAs as biomarker for triple-negative breast cancer
por: Shin, V Y, et al.
Publicado: (2015)

Serum endostatin levels are elevated in colorectal cancer and correlate with invasion and systemic inflammatory markers
por: Kantola, T, et al.
Publicado: (2014)

Endothelin B receptor expression correlates with tumour angiogenesis and prognosis in oesophageal squamous cell carcinoma
por: Tanaka, T, et al.
Publicado: (2014)

Nuclear osteopontin-c is a prognostic breast cancer marker
por: Zduniak, K, et al.
Publicado: (2015)

Overexpression of stathmin in oral squamous-cell carcinoma: correlation with tumour progression and poor prognosis
por: Kouzu, Y, et al.
Publicado: (2006)

Markers of systemic inflammation predict survival in patients with advanced renal cell cancer
por: Fox, P, et al.
Publicado: (2013)

Tumoral CD105 is a novel independent prognostic marker for prognosis in clear-cell renal cell carcinoma
por: Saroufim, A, et al.
Publicado: (2014)

Inverse correlation of HER2 with MHC class I expression on oesophageal squamous cell carcinoma
por: Maruyama, T, et al.
Publicado: (2010)

Consensus criteria for sensitive detection of minimal neuroblastoma cells in bone marrow, blood and stem cell preparations by immunocytology and QRT-PCR: recommendations by the International Neuroblastoma Risk Group Task Force
por: Beiske, K, et al.
Publicado: (2009)

∆Np63/p40 correlates with the location and phenotype of basal/mesenchymal cancer stem‐like cells in human ER(+) and HER2(+) breast cancers
por: Liu, Yajing, et al.
Publicado: (2019)

In breast carcinoma dysadherin expression is correlated with invasiveness but not with E-cadherin
por: Batistatou, A, et al.
Publicado: (2007)

Epstein-Barr virus as a marker of biological aggressiveness in breast cancer
por: Mazouni, C, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_sffdnoem5oqpfhgjklotkl0mrn